Literature DB >> 28419225

Epitope mapping of a new anti-Tn antibody detecting gastric cancer cells.

Nina Persson1, Nicolai Stuhr-Hansen1, Christian Risinger1, Stefan Mereiter2,3,4, António Polónia2,3,5, Karol Polom6, András Kovács1,7, Franco Roviello6, Celso A Reis2,3,4,8, Charlotte Welinder9,10, Lena Danielsson7, Bo Jansson9, Ola Blixt1.   

Abstract

Here, we introduce a novel scFv antibody, G2-D11, specific for two adjacent Tn-antigens (GalNAc-Ser/Thr) binding equally to three dimeric forms of the epitope, Ser-Thr, Thr-Thr and Thr-Ser. Compared to other anti-Tn reagents, the binding of G2-D11 is minimally influenced by the peptide structure, which indicates a high degree of carbohydrate epitope dominance and a low influence from the protein backbone. With a high affinity (KDapp = 1.3 × 10-8 M) and no cross-reactivity to either sialyl-Tn epitope or blood group A antigens, scFv G2-D11 is an excellent candidate for a well-defined anti-Tn-antigen reagent. Detailed immunohistochemical evaluation of tissue sections from a cohort of 80 patients with gastric carcinoma showed in all cases positive tumor cells. The observed staining was localized to the cytoplasm and in some cases to the membrane, whereas the surrounding tissue was completely negative demonstrating the usefulness of the novel Tn-antigen binding antibody.
© The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  N-acetylgalactosamine (GalNAc); Tn-antigen; gastric cancer; glycosylation; scFv; solid-phase peptide synthesis

Mesh:

Substances:

Year:  2017        PMID: 28419225     DOI: 10.1093/glycob/cwx033

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  5 in total

1.  Identification of Tn antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodies.

Authors:  Yasuyuki Matsumoto; Matthew R Kudelka; Melinda S Hanes; Sylvain Lehoux; Sucharita Dutta; Mark B Jones; Kathryn A Stackhouse; Gabrielle E Cervoni; Jamie Heimburg-Molinaro; David F Smith; Tongzhong Ju; Elliot L Chaikof; Richard D Cummings
Journal:  Glycobiology       Date:  2020-04-20       Impact factor: 4.313

2.  A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer.

Authors:  Ulrika Wendel; Nina Persson; Christian Risinger; Eva Bengtsson; Björn Nodin; Lena Danielsson; Charlotte Welinder; Gunilla Nordin Fredrikson; Bo Jansson; Ola Blixt
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

3.  A Graphene-Based Glycan Biosensor for Electrochemical Label-Free Detection of a Tumor-Associated Antibody.

Authors:  Filip Kveton; Anna Blsakova; Lenka Lorencova; Monika Jerigova; Dusan Velic; Ola Blixt; Bo Jansson; Peter Kasak; Jan Tkac
Journal:  Sensors (Basel)       Date:  2019-12-09       Impact factor: 3.576

4.  Core 1-derived mucin-type O-glycosylation protects against spontaneous gastritis and gastric cancer.

Authors:  Fei Liu; Jianxin Fu; Kirk Bergstrom; Xindi Shan; J Michael McDaniel; Samuel McGee; Xia Bai; Weichang Chen; Lijun Xia
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

5.  The Thomsen-Friedenreich Antigen: A Highly Sensitive and Specific Predictor of Microsatellite Instability in Gastric Cancer.

Authors:  Stefan Mereiter; Karol Polom; Coralie Williams; Antonio Polonia; Mariana Guergova-Kuras; Niclas G Karlsson; Franco Roviello; Ana Magalhães; Celso A Reis
Journal:  J Clin Med       Date:  2018-09-05       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.